CompletedPhase 2

Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80

United States128 participantsStarted 2004-10

Plain-language summary

The purpose of this study is to evaluate whether DHT-Gel, when applied daily to the skin, can relieve the symptoms of low testosterone in men aged 55-80. These symptoms include reduced muscle strength, increase fat mass, low libido, feeling blue or moody

Who can participate

Age range55 Years – 80 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Men aged 55-80 Serum Testosterone \< 275 Symptoms of Hypogonadism as determined by AMS scale In good overall health Exclusion Criteria: * Abnormal Prostate Exam for age Prostate or Breast Cancer Significant illness Weight \>300lbs Generalized skin disease Unstable sleep apnea

What they're measuring

Change in Body Composition

Trial details

NCT IDNCT00163566

SponsorASCEND Therapeutics

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2006-09

View on ClinicalTrials.gov More Hypogonadism trials